Evidence map›Paper›PMID 33682583›Full record

ArticleExpert review of vaccines2021

Luis M de la Maza, Toni L Darville, Sukumar Pal

Open access · greenAbstract read
In one paragraph

Article in Expert review of vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Impact of oralmSystems · 2025
    Article
  8. Article
  9. Profile ofHuman vaccines & immunotherapeutics · 2025
    Article
  10. Article
  11. ThebioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. mSphere · 2025
    Article
  14. Review
  15. Pathogenic and Protective Roles of Neutrophils inPathogens (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Frontiers in cellular and infection microbiology · 2025
    Article
  18. Article
  19. Article
  20. Viral Vector-BasedVaccines · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Luis M de la MazaDepartment of Pathology and Laboratory Medicine Medical Sciences, I, Room D440 University of California, Irvine, California, USA.
Toni L DarvilleDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Sukumar PalDepartment of Pathology and Laboratory Medicine Medical Sciences, I, Room D440 University of California, Irvine, California, USA.
University of California, Irvine · USUniversity of North Carolina at Chapel Hill · US

Funding

University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)U19AI144181 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI · 2019 to 2023
$10.7M
Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatisU19AI144184 · NIAID · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI COLEMAN, MATTHEW ADRIAN, DE LA MAZA, LUIS M · 2019 to 2023
$10.0M
NIAID NIH HHS U19 AI144181NIAID NIH HHS U19 AI144184
6 · The paper itself

Abstract

introductionAREAS COVERED: We focus the review on the progress made of our understanding of the immunological responses required for a vaccine to elicit protection, and on the antigens, adjuvants, routes of immunization and delivery systems that have been tested in animal models. PubMed and Google Scholar were used to search publication on these topics for the last 5 years and recent Reviews were examined. EXPERT OPINION: The first Phase 1 clinical trial of a

Indexed as

Chlamydia InfectionsChlamydia trachomatisAdjuvants, ImmunologicAnimalsAntibodies, BacterialBacterial VaccinesGenitaliaAdjuvants, ImmunologicAntibodies, BacterialBacterial VaccinesadjuvantsantigensChlamydia muridarumChlamydia trachomatisdelivery systemsimmunizationmouse modelroutes of immunizationsexually transmitted infectionsvaccines

Identifiers

PMID33682583
PMCPMC8934038
OpenAlexW3135168143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.